ArticleCancer research2019

Chemotherapy-Induced Distal Enhancers Drive Transcriptional Programs to Maintain the Chemoresistant State in Ovarian Cancer.

Stephen Shang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.